Bath salts in the emergency department: A survey of emergency clinicians' experience with bath salts-intoxicated patients

Journal of Addiction Medicine

Volumn 9, Issue 2, 2015, Pages 94-98

  Vazirian, Mohsen ^a   Jerry, Jason M ^a,b   James, Jeffrey ^c   Dale, Roman M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bath salts; emergency department; intoxication; toxicology screening

Indexed keywords

TRANQUILIZER;

AGE; AGGRESSION; DRUG ABUSE; DRUG EFFECTS; DRUG THERAPY; EMERGENCY HEALTH SERVICE; HALLUCINATIONS; HEALTH PERSONNEL ATTITUDE; HUMAN; QUESTIONNAIRE; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIOLENCE;

AGE FACTORS; AGGRESSION; AMPHETAMINE-RELATED DISORDERS; ATTITUDE OF HEALTH PERSONNEL; EMERGENCY SERVICE, HOSPITAL; HALLUCINATIONS; HUMANS; OHIO; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; TRANQUILIZING AGENTS; VIOLENCE;

EID: 84946489478     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000094     Document Type: Article

References (25)

1. American Association of Poison Control Centers. Bath salts data. Available at: https://aapcc.s3.amazonaws.com/files/library/Bath-Salts-Web-Data-through-12.2013-3.pdf. Published December 31, 2013. Accessed January 12, 2014
2. Antonowicz JL, Metzger AK, Ramanujam SL,. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 2011; 33: 640
3. Baumann MH, Partilla JS, Lehner KR, Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 2013; 38: 552-562
4. Bronstein AC, Spyker DA, Cantilena LR Jr, 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011; 49: 910-941
5. Camilleri A, Johnston MR, Brennan M, Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 2010; 197: 59-66
6. Center for Disease Control. Morbidity and Mortality Weekly Report: Emergency department visits after use of a drug sold as Bath Salts-Michigan, November 13, 2010-March 31., 2011. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6019a6.htm. Updated May 20, 2011. Accessed July 8, 2013
7. Coppola M, Mondola R,. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts or plant food. Toxicol Lett 2012; 211: 144-149
8. Forrester MB,. Synthetic cathinone exposures reported to Texas poison centers. Am J Drug Alcohol Abuse 2012; 38: 609-615
9. Forrester MB,. Adolescent synthetic cathinone exposures reported to Texas poison centers. Pediatr Emerg Care 2013; 29: 151-155
10. Gunderson EW, Kirkpatrick MG, Willing LM, Substituted cathinone products: a new trend in bath salts and other designer stimulant drug use. J Addict Med 2013; 7: 153-162
11. International Narcotics Control Board. The report of the International Narcotics Control Board for 2012. Available at: http://www.incb.org/documents/Publications/AnnualReports/AR2012/AR-2012-E.pdf. Published January 2013. Accessed January 12, 2014
12. Jerry J, Collins G, Streem D,. Synthetic legal intoxicating drugs: the emerging incense and bath salt phenomenon. Cleve Clin J Med 2012; 79: 258-264
13. Marinetti LJ, Antonides HM,. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 2013; 37: 135-146
14. National Drug Intelligence Center. Situation report-synthetic cathinones (bath salts): an emerging domestic threat. Available at: http://www.justice.gov/archive/ndic/pubs44/44571/44571p.pdf. Published July 2011. Accessed July 8, 2013
15. Penders TM, Gestring RE, Vilensky DA,. Intoxication delirium following use of synthetic cathinone derivatives. Am J Drug Alcohol Abuse 2012; 38: 616-617
16. Prosser JM, Nelson LS,. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012; 8: 33-42
17. Psychonaut Web Mapping Research Group. Mephedrone report. Available at: http://www.psychonautproject.eu/documents/reports/Mephedrone.pdf. Updated March 1, 2010. Accessed July 8, 2013
18. Simmler LD, Buser TA, Donzelli M, Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013; 168: 458-470
19. Spiller HA, Ryan ML, Weston RG, Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49: 499-505
20. Stogner JM, Miller BL,. Investigating the bath salt panic: the rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev 2013; 32: 545-549
21. Synthetic Drug Abuse Prevention Act of 2012. Available at: http://www.govtrack.us/congress/bills/112/s3190/text. Effective May 16, 2012. Accessed July 18, 2013
22. Warrick BJ, Hill M, Hekman K, A 9-State Analysis of Designer Stimulant, Bath Salt, Hospital Visits Reported to Poison Control Centers. Ann Emerg Med 2013; 62: 244-251
23. Wood KE,. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr 2013; 163: 213-216
24. Wood DM, Davies S, Greene SL, Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila. 2010; 48: 924-927
25. Zawilska JB, Wojcieszak J,. Designer cathinones-an emerging class of novel recreational drugs. Forensic Sci Int 2013; 231: 42-53